Anandappa, S. Y. et al. (2000). Variant estrogen receptor alpha mRNAs in human breast cancer specimens. International Journal of Cancer, 88, 209–216.
Badger, A. M. et al. (1999). Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis. Journal of Pharmacology and Experimental Therapeutics, 291, 1380–1386.
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D. and Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics, 39, 17–23.
Birge, S. J. (1997). The role of estrogen in the treatment of Alzheimer's disease. Neurology, 48, S36–41.
Brandi, M. L. et al. (1999). Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochemical and Biophysical Research Communications, 265, 335–338.
Cai, Q. et al. (2003). Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiology Biomarkers and Prevention, 12, 853–859.
Chiu, H. F. K., Lee, H. C., Chung, W. S. and Kwong, P. K. (1994). Reliability and validity of the Cantonese version of the Min-Mental State Examination – a preliminary study. Journal of the Hong Kong College of Psychiatrists, 4, 25–28.
Dijkstra, A. et al. (2006). Estrogen receptor 1 polymorphisms are associated with airway hyperresponsiveness and lung function decline, particularly in female subjects with asthma. Journal of Allergy and Clinical Immunology, 117, 604–611.
Garcia Pedrero, J. M., Zuazua, P., Martinez-Campa, C., Lazo, P. S. and Ramos, S. (2003). The naturally occurring variant of estrogen receptor (ER) ERDeltaE7 suppresses estrogen-dependent transcriptional activation by both wild-type ERalpha and ERbeta. Endocrinology, 144, 2967–2976.
Henderson, V. W., Benke, K. S., Green, R. C., Cupples, L. A. and Farrer, L. A. (2005). Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. Journal of Neurology Neurosurgery and Psychiatry, 76, 103–105.
International HapMap Consortium (2003). The International HapMap Project. Nature, 426, 789–796.
Jaffe, A. B., Toran-Allerand, C. D., Greengard, P. and Gandy, S. E. (1994). Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. Journal of Biological Chemistry, 269, 13065–13068.
Ji, Y., Urakami, K., Wada-Isoe, K., Adachi, Y. and Nakashima, K. (2000). Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia. Dementia and related Geriatrics Cognitive Disorders, 11, 119–122.
Kang, H. J. et al. (2002). Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Cancer Letters, 178, 175–180.
Lambert, J. C. et al. (2001). Are the estrogen receptors involved in Alzheimer's disease? Neuroscience Letters, 306, 193–197.
Li, G. et al. (1995). Age at onset and familial risk in Alzheimer's disease. American Journal of Psychiatry, 152, 424–430.
Lin, G. F. et al. (2003). Polymorphism of alpha-estrogen receptor and aryl hydrocarbon receptor genes in dementia patients in Shanghai suburb. Acta Pharmacologica Sinica, 24, 651–656.
Ma, S. L., Tang, N. L., Lam, L. C. and Chiu, H. F. (2005). The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiology of Aging, 26, 1005–1010.
Maraganore, D. M. et al. (2006). Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. Journal of the American Medical Association, 296, 661–670.
Maruyama, H. et al. (2000). Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Archives of Neurology, 57, 236–240.
McKhann, G. et al. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.
Myers, A. et al. (2002). Full genome screen for Alzheimer disease: stage II analysis. American Journal of Medical Geneti, 114, 235–244.
Roodi, N. et al. (1995). Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. Journal of National Cancer Institute, 87, 446–451.
Shumaker, S. A. et al. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Journal of the American Medical Association, 291, 2947–2958.
Slopien, R. et al. (2003). Influence of hormonal replacement therapy on the regional cerebral blood flow in postmenopausal women. Maturitas, 46, 255–262.
Srivastava, R. A. et al. (1997). Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. Journal of Biological Chemistry, 272, 33360–33366.
Stephens, M., Smith, N. J. and Donnelly, P. (2001). A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics, 68, 978–989.
Tang, M. X. et al. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348, 429–432.
Tang, N. L., Pharoah, P. D., Ma, S. L. and Easton, D. F. (2006a). Evaluation of an algorithm of tagging SNPs selection by linkage disequilibrium. Clinical Biochemistry, 39, 240–243.
Tang, N. L. et al. (2006b). A relook into the association of the estrogen receptor [alpha] gene (PvuII, XbaI) and adolescent idiopathic scoliosis: a study of 540 Chinese cases. Spine, 31, 2463–2468.
Urabe, M. et al. (1996). Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women. Endocrine Journal, 43, 737–742.
Usui, C. et al. (2006). No genetic association between the myeloperoxidase gene -463 polymorphism and estrogen receptor-alpha gene polymorphisms and Japanese sporadic Alzheimer's disease. Dementia and Related Geriatric Cognitive Disorders, 21, 296–299.
Wang, J. et al. (2007). Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Breast Cancer Research and Treatment.
Waring, S. C. et al. (1999). Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology, 52, 965–970.
Yaffe, K., Lui, L. Y., Grady, D., Stone, K. and Morin, P. (2002). Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biological Psychiatry, 51, 677–682.
Zavratnik, A., Prezelj, J., Kocijancic, A. and Marc, J. (2007). Exonic, but not intronic polymorphisms of ESR1 gene might influence the hypolipemic effect of raloxifene. Journal of Steroid Biochemistry and Molecular Biology, 104, 22–26.
Zhang, K. and Jin, L. (2003). HaploBlockFinder: haplotype block analyses. Bioinformatics, 19, 1300–1301.